Windingoudi Rimwagna Christian Ouédraogo | Pharmacology | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Windingoudi Rimwagna Christian Ouédraogo — Institut de Recherche en Sciences de la Santé, Burkina Faso.

Windingoudi Rimwagna Christian Ouédraogo
Affiliation Institut de Recherche en Sciences de la Santé
Country Burkina Faso
Scopus ID 58145355200
Documents 4
Citations 10
h-index 1
Subject Area Pharmacology
Event Scientific World Research Awards
ORCID 0000-0001-8365-5579

Windingoudi Rimwagna Christian Ouédraogo is a pharmacology researcher. His documented research activities include pharmacological investigations of medicinal plants, natural products, cardiovascular effects, and experimental models of disease.[1]

Abstract

This profile presents the research activities and scholarly publications of Windingoudi Rimwagna Christian Ouédraogo, whose work focuses on pharmacology and medicinal plant research. His documented publications investigate plant-derived extracts, biological activity, toxicity, vascular protection, and potential therapeutic applications.[1]

Keywords

Pharmacology, medicinal plants, natural products, phytochemistry, cardiovascular research, antihypertensive activity, antioxidant activity, toxicity assessment, vascular endothelium, and drug discovery.

Introduction

Pharmacological research examines the biological effects of substances and their potential therapeutic applications. Research into medicinal plants contributes experimental evidence concerning chemical constituents, safety, and biological activity. Ouédraogo’s listed publications reflect these themes through investigations involving plant extracts and experimental cardiovascular models. [2]

Research Profile

According to his research record, Ouédraogo has worked as a Pharmacology Research Engineer at the Institut de Recherche en Sciences de la Santé since December 2019. His recorded keywords include pharmacology, phytochemistry, natural products, medicinal plants, and life and human sciences. [1]

Research Contributions

His studies investigate the pharmacological properties of plant extracts, including potential antihypertensive, antioxidant, and vascular protective effects. Other publications examine acute toxicity, phytochemical profiles, and experimental therapeutic effects. These studies contribute to the scientific investigation of natural products without, by themselves, establishing clinical efficacy in humans. [3]

Publications

The ORCID record lists six works, including studies published in 2023, 2024, 2025, and 2026. Examples include research on Phaseolus vulgaris extracts and vascular protection, Flemingia faginea phenolic compounds, and the pharmacological effects of Ampelocissus africana. The record covers the associated journals and DOIs for the publications. [1]

Research Impact

The bibliometric figures are four documents, ten citations, and an h-index of one. These figures are profile data and should be checked against the current Scopus record before formal publication. Citation counts and h-index values describe selected aspects of scholarly output but do not independently establish research quality or practical impact. [4]

Award Suitability

The Best Researcher Award category may recognize contributions to scientific investigation, publication, collaboration, and disciplinary development. Ouédraogo’s documented pharmacology publications provide material for consideration within this category. Eligibility and final award decisions should follow the official event criteria and independent verification of the researcher’s achievements. [5]

Conclusion

Windingoudi Rimwagna Christian Ouédraogo’s recorded research focuses on pharmacology, medicinal plants, and the investigation of biologically active natural products. His published studies provide verifiable starting points for evaluating his academic profile. Recognition should be based on documented achievements and the award organizer’s published assessment criteria.

References

  1. ORCID. (n.d.). Windingoudi Rimwagna Christian Ouédraogo: Researcher record and works. ORCID.
    https://orcid.org/0000-0001-8365-5579
  2. Ouédraogo, W. R. C., et al. (2026). Antihypertensive and Vascular Endothelium Protection Effect of the Ethyl Acetate Fraction of Phaseolus vulgaris Pods in L-NAME-induced Hypertensive Mice. Biomedical & Pharmacology Journal.
    https://doi.org/10.13005/bpj/3524
  3. Ouédraogo, W. R. C., et al. (2026). Evaluation of organic acids, cytotoxicity, oral acute toxicity and diuretic effect of Phaseolus vulgaris crops ethyl acetate extract for cardiovascular health improvement. Journal of Drug Delivery and Therapeutics.
    https://doi.org/10.22270/jddt.v16i5.7765
  4. Elsevier. (n.d.). Scopus author details: Windingoudi Rimwagna Christian Ouédraogo, Author ID 58145355200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58145355200
  5. Scientific World Research Awards. (n.d.). Official award website.
    https://scientificworld.net/

Ahmed Sobhy Abdelrahim Abdallah Darwish | Pharmaceutical Analysis | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Ahmed Sobhy Abdelrahim Abdallah Darwish — Egyptian International Pharmaceutical Industries Company, Egypt

Ahmed Sobhy Abdelrahim Abdallah Darwish
Affiliation Egyptian International Pharmaceutical Industries Company
Country Egypt
Scopus ID 59519037100
Documents 20
Citations 185
h-index 7
Subject Area Pharmaceutical Analysis
Event Scientific World Research Awards
ORCID 0009-0009-9000-3777

Ahmed Sobhy Abdelrahim Abdallah Darwish is a researcher and pharmaceutical-analysis professionalist. His documented research profile includes analytical chemistry, green chemistry, chromatography, pharmaceutical quality control, dissolution analysis, and environmentally conscious analytical methodologies. [1]

Abstract

The research profile of Ahmed Sobhy Abdelrahim Abdallah Darwish is centered on pharmaceutical analysis and analytical methodology, with documented interests in chromatography, and green analytical chemistry. His ORCID record lists multiple peer-reviewed research outputs, and technical experience in pharmaceutical quality-control and research-and-development environments. [1]

Keywords

Pharmaceutical Analysis; Analytical Chemistry; Green Chemistry; High-Performance Liquid Chromatography; Stability-Indicating Methods; Pharmaceutical Quality Control; Dissolution Testing; Chromatography; Sustainable Analytical Methods.

Introduction

Pharmaceutical analysis provides analytical procedures for identifying, measuring, and evaluating substances used in medicines and pharmaceutical formulations. Darwish’s documented professional and scholarly activities connect these analytical requirements with chromatographic methodology, stability studies, dissolution assessment, and environmentally conscious analytical practices. [2]

Research Profile

The profile identifies expertise involving high-performance liquid chromatography, gas chromatography, atomic absorption spectroscopy, thin-layer chromatography, dissolution testing, and inductively coupled plasma techniques. His professional history includes research-and-development responsibilities involving methodology, comparative in-vitro studies, and stress-stability studies. [1]

Research Contributions

The documented publications address analytical methods for pharmaceutical substances and formulations, including green and microscale HPLC approaches, dissolution monitoring, and assessment of analytical greenness. Several records specifically describe methods designed to reduce environmental burden while maintaining analytical performance, providing a recurring methodological theme within the research portfolio. [3]

Publications

Recent documented works include publications in Microchemical Journal, RSC Advances, Results in Chemistry, Food Analytical Methods, Talanta Open, ACS Omega, and related journals. Examples include studies of aescin and diethylamine salicylate, pharmaceutical impurities, stability-indicating methods, and environmentally conscious chromatographic procedures. [4]

Research Impact

The researcher profile reports 20 documents, 185 citations, and an h-index of 7. The record also documents participation in professional activities involving pharmaceutical standards and peer-review responsibilities, providing additional evidence of engagement with analytical and pharmaceutical research communities. [1]

Award Suitability

For recognition under the Best Researcher Award category of the Scientific World Research Awards, the documented profile provides information concerning scholarly publications, citations, analytical research, professional experience, and research-related service. [5]

Conclusion

Ahmed Sobhy Abdelrahim Abdallah Darwish’s documented academic and professional profile combines pharmaceutical analysis, green analytical chemistry, and pharmaceutical quality-control experience. His recorded publications and research activities demonstrate sustained involvement in analytical-method development and pharmaceutical applications.[1]

References

  1. ORCID. (2026). Ahmed Sobhy Darwish, ORCID iD 0009-0009-9000-3777. ORCID.
    https://orcid.org/0009-0009-9000-3777
  2. Darwish, A. S. (2025). An ecologically sound HPLC determination of levomenol in topical therapies using a certified reference material with green properties. Results in Chemistry.
    https://doi.org/10.1016/j.rechem.2025.102338
  3. Darwish, A. S., et al. (2026). A microscale optimized HPLC analysis of aescin and diethylamine salicylate topical gel formulations and raw materials in conjunction with environmentally friendly appraisal. Microchemical Journal.
    https://doi.org/10.1016/j.microc.2026.116848
  4. Huang, X.-C., Zhang, N., Darwish, A. S., & Ma, J.-K. (2026). An optimized green simultaneous HPLC analysis of dissolution rate monitoring for valsartan and sacubitril in tablet medications. RSC Advances.
    https://doi.org/10.1039/D6RA03367A
  5. Darwish, A. S., et al. (2026). Optimization and Validation of a Green Shelf Life HPLC Technique for Testing Sugammadex Sodium in Raw Material and Parenteral Medications. Biomedical Chromatography.
    https://doi.org/10.1002/bmc.70267

Thomas Birngruber | Pharmacokinetics | Best Industrial Research Award

Published on by Scientific World Research Awards

Best Industrial Research Award

Thomas Birngruber — JOANNEUM RESEARCH HEALTH, Austria.

Thomas Birngruber
Affiliation JOANNEUM RESEARCH HEALTH
Country Austria
Scopus ID 36569938300
Documents 57
Citations 1,209
h-index 18
Subject Area Pharmacokinetics
Event Scientific World Research Awards
ORCID 0000-0001-8827-4660

Thomas Birngruber is a researcher, whose research publication record includes studies addressing dermal, cerebral, and interstitial pharmacokinetic measurements and pharmaceutical delivery systems. His ORCID record identifies and documented a research portfolio containing pharmaceutical and biomedical studies. [1]

Abstract

Thomas Birngruber’s documented research profile is centered on pharmacokinetics, drug delivery, open flow microperfusion and related biomedical applications. Research profile focused on pharmacokinetics and associated pharmaceutical research methodologies. His ORCID record lists publications addressing dermal, cerebral and interstitial pharmacokinetic measurements, topical formulations and therapeutic agents. [2]

Keywords

Pharmacokinetics; open flow microperfusion; dermal drug delivery; topical pharmaceuticals; bioequivalence; cerebral microperfusion; drug transport; interstitial fluid; pharmaceutical research.

Introduction

The publication record associated with Birngruber includes studies spanning pharmaceutical sciences and biomedical research, with recurring attention to methods for measuring drug concentrations in biological tissues. Birngruber’s documented works apply experimental microperfusion approaches to investigate drug concentrations in skin, brain, and other interstitial compartments.[3]

Research Profile

The Research subject area is pharmacokinetics, while the documented works show particular activity in dermal pharmacokinetics, open flow microperfusion and topical drug research. Recent records include investigations of systemic redistribution, cutaneous bioequivalence and local drug concentrations.The profile also includes collaborative publications in pharmaceutical sciences, biomedical research, and drug-development applications.[4]

Research Contributions

Representative contributions include research using open flow microperfusion to investigate topical drug delivery, dermal pharmacokinetics, cerebral drug transport and interstitial-fluid measurements. The research record also includes collaborative studies involving advanced pharmaceutical formulations and therapeutic antibodies. [5]

Publications

The Research record reports the works displayed in its publication interface and includes recent articles such as a 2026 European Journal of Pharmaceutical Sciences study on cutaneous pharmacokinetic-based bioequivalence and a 2025 Journal of Controlled Release study concerning subcutaneous bioavailability of monoclonal antibodies. [2]

Research Impact

The researcher profile reports 57 documents, 1,209 citations and an h-index of 18. These quantitative indicators are presented as profile for the recognition article. These bibliometric figures provide quantitative indicators of publication and citation activity associated with the researcher profile. His documented  research portfolio containing pharmaceutical and biomedical studies.[1]

Award Suitability

For the Scientific World Research Awards, the nomination information identifies the recognition category as Best Industrial Research Award and the subject area as Pharmacokinetics. The documented publication portfolio provides a research basis for describing work in pharmaceutical and biomedical research without assigning claims beyond the record

Conclusion

Thomas Birngruber’s documented profile combines pharmacokinetic research with methodological work involving open flow microperfusion, drug delivery and tissue-level measurement. The ORCID record provides identifiable employment and publication information, while the supplied bibliometric data summarize the research profile presented for this award article.[1]

References

  1. ORCID. (2026). Thomas Birngruber, ORCID iD 0000-0001-8827-4660. ORCID.
    https://orcid.org/0000-0001-8827-4660
  2. Crossref. (2026). The Impact of Systemic Redistribution on Cutaneous Pharmacokinetic-Based Bioequivalence. European Journal of Pharmaceutical Sciences.
    https://doi.org/10.1016/j.ejps.2026.107673
  3. Elsevier. (2025). Predicting human subcutaneous bioavailability of monoclonal antibodies using an open flow microperfusion porcine model. Journal of Controlled Release.
    https://doi.org/10.1016/j.jconrel.2025.114401
  4. Elsevier. (2024). Cutaneous pharmacokinetics-based bioequivalence: A clinical dermal open flow microperfusion verification study. European Journal of Pharmaceutical Sciences.
    https://doi.org/10.1016/j.ejps.2024.106827
  5. Elsevier. (2023). Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion. International Journal of Pharmaceutics.
    https://doi.org/10.1016/j.ijpharm.2023.123269

Hanan Aati | Pharmacy | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Hanan Aati — King Saud University, Saudi Arabia

Hanan Aati
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 57203870584
Documents 65
Citations 1,045
h-index 20
Subject Area Pharmacy
Event Scientific World Research Awards
ORCID 0000-0003-1598-2273

Hanan Aati is a researcher in Pharmacy with documented work involving natural products, bioactive compounds, biological activities, and molecular approaches. Her record identifies research interests including herbs, biological activity, natural products, and essential oils. [1]

Abstract

Hanan Aati’s documented research profile is centered on pharmacognosy and natural-product research. Her publication record also demonstrates interdisciplinary use of analytical chemistry, biological assays, molecular modelling, and metabolomic approaches. [1]

Keywords

Pharmacy; Pharmacognosy; Natural Products; Phytochemistry; Essential Oils; Bioactive Compounds; Medicinal Plants; Molecular Docking; Metabolomics; Biological Activity.

Introduction

Natural-product pharmacy combines the identification of chemical constituents with evaluation of biological properties and potential pharmaceutical relevance. Aati’s record places her academic appointment in Pharmacognosy and documents a sustained research focus on natural sources and secondary metabolites. [1]

Research Profile

The profile includes studies using phytochemical characterization, GC–MS, NMR-related approaches, essential-oil investigation, molecular docking, and biological evaluation. The ORCID record lists 47 works and records peer-review activity across journals in pharmaceutical and natural-product research. [1]

Research Contributions

Documented publications examine medicinal plants and natural materials through complementary chemical and biological methods. Examples include work on essential oils, phytochemical profiles, antimicrobial activity, antioxidant properties, molecular docking, and nanoformulations, illustrating the multidisciplinary scope of the research record. [4]

Publications

The Selected records include publications in Results in Chemistry, Journal of Agriculture and Food Research, Pharmaceutics, Scientific Reports, Frontiers in Pharmacology, Molecules, Heliyon, and related journals.

Research Impact

The researcher metrics report 65 documents, 1,045 citations, and an h-index of 20. These figures are presented as the profile information and may change as indexing databases update their records. The research profile independently documents the researcher’s identity, affiliation, keywords, works, and identifiers. [2]

Award Suitability

The documented combination of pharmacognosy, natural-product chemistry, biological evaluation, and interdisciplinary publication activity provides relevant evidence for consideration within a Best Researcher Award profile in Pharmacy. The assessment should be based on the award’s formal criteria and independently verified research records rather than on any single bibliometric measure.

Conclusion

Hanan Aati’s available academic record presents a sustained research profile in Pharmacognosy and Pharmacy, with emphasis on natural products and bioactive compounds. Her ORCID record and associated publications provide identifiable evidence of scholarly activities and research outputs. [1]

References

  1. ORCID. (n.d.). Dr. Hanan Aati, ORCID record 0000-0003-1598-2273. ORCID.
    https://orcid.org/0000-0003-1598-2273
  2. Scopus Author Profile: Hanan Aati, Scopus Author ID 57203870584.
    https://www.scopus.com/authid/detail.uri?authorId=57203870584
  3. Khan, D. A., et al., including Aati, H. Y. (2026). Functional food potential of Suaeda fruticosa (L.) Forssk. Journal of Agriculture and Food Research.
    https://doi.org/10.1016/j.jafr.2026.102758
  4. Hasaballah, N. H., AlGhamdi, S. A., et al., including Aati, H. (2026). Development of an Artemisia absinthium Essential Oil Nanoemulsion. Colloids and Interfaces.
    https://doi.org/10.3390/colloids10010010
  5. Al-Qahtani, J., Fatima, Z., Aati, H. Y., et al. (2025). Analgesic and anti-inflammatory potential of Ficus Palmata Forssk. Scientific Reports.
    https://doi.org/10.1038/S41598-025-25430-5

Liang Liu | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Best Researcher Award

Researcher Information
Researcher Liang Liu
Affiliation Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University
Country China
Scopus ID 56543839300
Documents 206
Citations 6763
h-index 45
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-7826-3877

Liang Liu – Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University

Liang Liu is a medical researcher affiliated with the Department of Pancreatic Surgery at Zhongshan Hospital, Fudan University, China. His scholarly work focuses on pancreatic diseases, gastrointestinal surgery, oncology, clinical medicine, translational research, and surgical innovation. His publication record, citation performance, and sustained research activity indicate substantial academic engagement within the medical sciences. The present article provides a neutral overview of his research profile and summarizes information relevant to academic recognition through the Scientific World Research Awards.[1]

Abstract

Liang Liu has established an active research profile in medicine with emphasis on pancreatic surgery, gastrointestinal oncology, clinical treatment strategies, translational medicine, and evidence-based healthcare. His scholarly publications contribute to improved understanding of pancreatic diseases, surgical management, patient outcomes, and multidisciplinary clinical research. Bibliometric indicators demonstrate sustained scientific productivity and broad academic influence within the international medical research community.[1]

Keywords

  • Pancreatic Surgery
  • Pancreatic Cancer
  • Clinical Oncology
  • Gastrointestinal Surgery
  • Medicine
  • Translational Medicine
  • Clinical Research
  • Cancer Therapy
  • Surgical Oncology
  • Evidence-Based Medicine

Introduction

Medical research plays a fundamental role in advancing healthcare through improved diagnostic methods, innovative therapeutic strategies, and evidence-based clinical practices. Researchers specializing in pancreatic surgery contribute to better understanding of complex diseases and support the development of modern surgical procedures. Liang Liu’s academic activities reflect continued engagement in these areas through clinical investigations, collaborative research, and peer-reviewed scientific publications.[2]

Research Profile

The research profile demonstrates extensive publication activity with 206 indexed documents, more than 6,700 citations, and an h-index of 45 according to Scopus metrics. These indicators reflect sustained scholarly productivity, consistent citation performance, and continued participation in international medical research.[1]

  • Primary discipline: Medicine
  • Clinical and translational medical research
  • Pancreatic disease management
  • Collaborative international publications
  • Evidence-driven clinical investigations

Research Contributions

Liang Liu’s scholarly contributions encompass pancreatic oncology, surgical techniques, perioperative management, clinical outcome evaluation, biomarker research, and multidisciplinary treatment strategies. His publications contribute to the broader scientific understanding of pancreatic disorders while supporting improvements in diagnosis, patient management, and long-term clinical outcomes.[2]

Publications

Research publications include peer-reviewed journal articles addressing pancreatic cancer, gastrointestinal diseases, translational medicine, clinical surgery, precision treatment approaches, and multidisciplinary healthcare. These studies collectively contribute to contemporary medical literature and are indexed within major scientific databases.[3]

  • Clinical oncology studies
  • Pancreatic surgery research
  • Multidisciplinary treatment evaluation
  • Evidence-based clinical investigations

Research Impact

Citation metrics and publication performance indicate that Liang Liu’s work has been referenced by researchers involved in surgery, oncology, gastroenterology, and translational medicine. Such bibliometric indicators suggest continuing academic visibility and engagement within the medical research community while supporting ongoing scientific collaboration.[1]

Award Suitability

Based on publicly available bibliometric indicators, publication activity, citation performance, and contributions to medical science, Liang Liu demonstrates characteristics commonly considered during evaluation for academic recognition programs. Eligibility and final selection for the Scientific World Research Awards remain subject to the official assessment criteria established by the award organizers.[4]

Conclusion

Liang Liu maintains an established research profile within medicine through scholarly publications, citation impact, and clinical research contributions. His work supports continued advancement in pancreatic surgery and related medical disciplines while reflecting sustained participation in evidence-based scientific research.[1]

References

  1. Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
    https://www.sciencedirect.com/science/article/abs/pii/S0304419X22000014
  2. Patterns and predictors of pancreatic neuroendocrine tumor prognosis: Are no two leaves alike?
    https://www.researchgate.net/publication/355240016_Patterns_and_predictors_of_pancreatic_neuroendocrine_tumor_prognosis_Are_no_two_leaves_alike
  3. Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors
    https://www.sciencedirect.com/science/article/abs/pii/S1530891X21011794
  4. Scientific World Research Awards.
    https://scientificworld.net/

Ozlem Bingol Ozakpinar | Pharmacy | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Dr. Ozlem Bingol Ozakpinar | Pharmacy | Research Excellence Award

Professor | Marmara University | Turkey

Prof. Dr. Ozlem Bingol Ozakpinar is a leading researcher in pharmaceutical chemistry and biomedical sciences, focusing on drug discovery, nanocarriers, and anticancer and antiviral studies. Her expertise includes molecular docking, chemical synthesis, toxicological evaluation, and nanotechnology-based drug delivery. She has published 77 Scopus-indexed documents with 1,224 citations and an h-index of 20, reflecting strong academic impact. Recognized for her contributions, her work advances innovative therapeutic strategies and strengthens global progress in pharmaceutical and biomedical research.

Citation Metrics (Scopus)

1224
900
600
300
0

Citations

1224

Documents

77

h-index

20

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View Google Scholar Profile

Featured Publications